Best Agrolife Reports Q3 FY26 Results, Focused on Patented Products and Operational Efficiency
Best Agrolife Limited, a leading player in India’s agro-chemical sector, announced its financial results for the third quarter and nine months ended December 31, 2025. The company's performance was impacted by erratic and unseasonal rainfall, lower pest incidences, and elevated generic inventory at the trade level. Despite these challenges, Best Agrolife achieved strong acceptance for its two newly launched patented combinations, BestMan and Fetagen. The company also focused on cost optimization, inventory rationalization, and disciplined receivables management, which drove margin expansion and OPEX reduction. Looking ahead, Best Agrolife is well-positioned to improve growth with the launch of three additional patented combinations in the next 3-9 months.
Key Highlights
- Revenue from operations in Q3 FY26 was 202.9 crore, down from 227.4 crore in Q3 FY25.
- Gross margin for Q3 FY26 was 65 crore, down from 89.0 crore in the same period last year.
- EBITDA for Q3 FY26 was a gain of 3.8 crore, improving over a loss of 5.8 crore in Q3 FY25.
- PAT loss for Q3 FY26 was 12.7 crore, improving from a loss of 24.2 crore in the corresponding quarter last year.
- For 9M FY26, revenue from operations stood at 1,101.1 crore, compared to 1,540 crore in the same period last year.